HomeSVA • TSE
add
Sernova Biotherapeutics Inc
Previous close
$0.21
Day range
$0.19 - $0.21
Year range
$0.15 - $0.47
Market cap
60.79M CAD
Avg Volume
158.80K
P/E ratio
-
Dividend yield
-
Primary exchange
TSE
In the news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.80M | -52.13% |
Net income | -5.70M | 41.55% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.75M | 52.11% |
Effective tax rate | -0.11% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.21M | -92.23% |
Total assets | 3.08M | -83.43% |
Total liabilities | 21.01M | 42.53% |
Total equity | -17.93M | — |
Shares outstanding | 328.48M | — |
Price to book | -4.10 | — |
Return on assets | -226.30% | — |
Return on capital | 80.63% | — |
Cash Flow
Net change in cash
| (CAD) | Jan 2025info | Y/Y change |
|---|---|---|
Net income | -5.70M | 41.55% |
Cash from operations | -4.83M | -13.62% |
Cash from investing | — | — |
Cash from financing | 22.38K | 151.87% |
Net change in cash | -4.80M | -117.18% |
Free cash flow | -2.23M | -189.70% |
About
Founded
2006
Headquarters
Website
Employees
17
